Cable Hill Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Cable Hill Partners, LLC

$964 Million
Q3 2024

A detailed history of Cable Hill Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Cable Hill Partners, LLC holds 1,024 shares of VRTX stock, worth $514,508. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,024

Previous 1,017 0.69%

Holding current value

$514,508

Previous $476,000 -0.0%

% of portfolio

0.05%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$460.0 - $505.78 $3,220 - $3,540	7 Added 0.69%	1,024 $476,000
Q2 2024 Jul 22, 2024	BUY	$392.81 - $485.53 $399,487 - $493,784	1,017 New	1,017 $476,000
Q3 2023 Oct 27, 2023	BUY	$338.18 - $362.46 $63,239 - $67,780	187 Added 18.97%	1,173 $407,000
Q2 2023 Jul 19, 2023	SELL	$314.42 - $351.91 $83,950 - $93,959	-267 Reduced 21.31%	986 $346,000
Q1 2023 May 04, 2023	SELL	$283.23 - $323.1 $9,913 - $11,308	-35 Reduced 2.72%	1,253 $394,000
Q4 2022 Feb 06, 2023	BUY	$285.76 - $321.48 $7,429 - $8,358	26 Added 2.06%	1,288 $371,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $38,610 - $43,079	141 Added 12.58%	1,262 $365,000
Q2 2022 Aug 11, 2022	BUY	$234.96 - $292.55 $42,997 - $53,536	183 Added 19.51%	1,121 $316,000
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $1,992 - $2,348	9 Added 0.97%	938 $245,000
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $164,442 - $207,585	929 New	929 $204,000
Q2 2019 Aug 06, 2019	SELL	$164.61 - $190.37 $36,049 - $41,691	-219 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$163.73 - $194.7 $1,964 - $2,336	-12 Reduced 5.19%	219 $40,000
Q4 2018 Feb 12, 2019	BUY	$151.91 - $192.21 $1,671 - $2,114	11 Added 5.0%	231 $38,000
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $38,577 - $44,330	-230 Reduced 51.11%	220 $41,000
Q2 2018 Aug 03, 2018	SELL	$145.72 - $169.96 $5,391 - $6,288	-37 Reduced 7.6%	450 $76,000
Q1 2018 Apr 20, 2018	SELL	$151.6 - $177.13 $10,005 - $11,690	-66 Reduced 11.93%	487 $75,000
Q4 2017 Feb 22, 2018	SELL	$137.28 - $155.55 $10,021 - $11,355	-73 Reduced 11.66%	553 $85,000
Q3 2017 Oct 27, 2017	BUY	$148.13 - $162.24 $71,398 - $78,199	482 Added 334.72%	626 $95,000
Q2 2017 Aug 14, 2017	BUY	N/A	144	144 $18,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cable Hill Partners, LLC with notifications on news.

Account

Cable Hill Partners, LLC Vertex Pharmaceuticals Inc Transaction History